Kyoto global consensus report on Helicobacter pylori gastritis

K Sugano, J Tack, EJ Kuipers, DY Graham…�- Gut, 2015 - gut.bmj.com
Objective To present results of the Kyoto Global Consensus Meeting, which was convened
to develop global consensus on (1) classification of chronic gastritis and duodenitis,(2)�…

Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization regions

A Savoldi, E Carrara, DY Graham, M Conti…�- Gastroenterology, 2018 - Elsevier
Background & Aims In 2017, the World Health Organization (WHO) designated
clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and�…

Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report

P Malfertheiner, F Megraud, CA O'Morain, J Atherton…�- Gut, 2012 - gut.bmj.com
Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at�…

[HTML][HTML] Diagnosis of Helicobacter pylori infection: Current options and developments

YK Wang, FC Kuo, CJ Liu, MC Wu…�- World Journal of�…, 2015 - ncbi.nlm.nih.gov
Accurate diagnosis of Helicobacter pylori (H. pylori) infection is a crucial part in the effective
management of many gastroduodenal diseases. Several invasive and non-invasive�…

Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition

M Kato, H Ota, M Okuda, S Kikuchi, K Satoh…�- …, 2019 - Wiley Online Library
Abstract Background Since “Helicobacter pylori (H. pylori) infection” was set as the
indication in the Japanese Society for Helicobacter Research (JSHR) Guidelines 2009�…

Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III�…

K Murakami, Y Sakurai, M Shiino, N Funao…�- Gut, 2016 - gut.bmj.com
Objective The objective of this study was to assess the efficacy, safety and tolerability of
vonoprazan, a novel potassium-competitive acid blocker, as a component of Helicobacter�…

Epidemiology of Helicobacter pylori Infection and Public Health Implications

KL Goh, WK Chan, S Shiota, Y Yamaoka�- Helicobacter, 2011 - Wiley Online Library
This review summarizes studies on the epidemiology and public health implications of
Helicobacter pylori published in peer‐reviewed journals from April 2010 through March�…

[HTML][HTML] Gastric cancer: prevention, screening and early diagnosis

V Pasechnikov, S Chukov, E Fedorov…�- World journal of�…, 2014 - ncbi.nlm.nih.gov
Gastric cancer continues to be an important healthcare problem from a global perspective.
Most of the cases in the Western world are diagnosed at late stages when the treatment is�…

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin�…

P Malfertheiner, F Bazzoli, JC Delchier, K Celi�ski…�- The Lancet, 2011 - thelancet.com
Background Helicobacter pylori is associated with benign and malignant diseases of the
upper gastrointestinal tract, and increasing antibiotic resistance has made alternative�…

The epidemiology and prevention of gastric cancer

KM Fock�- Alimentary pharmacology & therapeutics, 2014 - Wiley Online Library
Background Gastric cancer can be divided into cardia and noncardia gastric
adenocarcinoma (NCGA). Non cardia gastric cancer is a disease that has declined in global�…